Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7793)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun YT, Zhang YX, Tang H, Mao Q, Wang XZ, Zhang LY, Chen H, Zhong YN, Lin SM, Zhang DZ. Clinical characteristics and current management of hepatitis B and C in China. World J Gastroenterol 2014; 20(37): 13582-13590 [PMID: 25309089 DOI: 10.3748/wjg.v20.i37.13582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13582.htm |
| Number | Citing Articles |
| 1 |
Feng Zhou, Weidong Jia, Shuo Yang, Ge Chen, Guanhai Li, Yueping Li, Yingfang Liang, Yi Yang, Yanhui Gao, Yue Chen. Antiviral drug Utilization and Annual Expenditures for Patients with Chronic HBV Infection in Guangzhou, China, in 2008–2015. Antiviral Therapy 2019; 24(6): 405 doi: 10.3851/IMP3326
|
| 2 |
Xiao-Wei Xu, Xiao-Xin Wu, Ke-Da Chen, Da-Zhi Chen, Hui-Lin Ou, Jun-Wei Su, Hai-Ying Yu, Hang-Ping Yao, Lan-Juan Li. Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China. Medicine 2018; 97(38): e12403 doi: 10.1097/MD.0000000000012403
|
| 3 |
Mingjuan Tan, Ajeet S Bhadoria, Fuqiang Cui, Alex Tan, Judith Van Holten, Philippa Easterbrook, Nathan Ford, Qin Han, Ying Lu, Marc Bulterys, Yvan Hutin. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2021; 6(2): 106 doi: 10.1016/S2468-1253(20)30307-1
|
| 4 |
Vinh D Vu, Ailinh Do, Nghia H Nguyen, Lily H Kim, Huy N Trinh, Huy A Nguyen, Khanh K Nguyen, My Nguyen, Andrew Huynh, Mindie H Nguyen. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterology 2015; 2(1): e000060 doi: 10.1136/bmjgast-2015-000060
|
| 5 |
Nura Bello, Shuaibu A. Hudu, Ahmed S. Alshrari, Mustapha U. Imam, Abdulgafar O. Jimoh. Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review. Pathogens 2024; 13(7): 554 doi: 10.3390/pathogens13070554
|
| 6 |
Iris W. Liou, Mindie H. Nguyen. The Cascade of Care in Chronic Hepatitis B. Current Hepatology Reports 2016; 15(4): 209 doi: 10.1007/s11901-016-0316-8
|
| 7 |
Hao Feng, Jie Yin, Ya-Ping Han, Xiao-Ying Zhou, Su Chen, Li Yang, Jin-Rui Yan, Guo-Xin Zhang. Sustained Changes of Treg and Th17 Cells During Interferon-α Therapy in Patients with Chronic Hepatitis B. Viral Immunology 2015; 28(8): 412 doi: 10.1089/vim.2015.0024
|
| 8 |
Matthew S. Chang, Mindie H. Nguyen. Epidemiology of hepatitis B and the role of vaccination. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 239 doi: 10.1016/j.bpg.2017.05.008
|
| 9 |
Yu Zhijian, Li Hui, Yao Weiming, Lin Zhanzhou, Chen Zhong, Zheng Jinxin, Wang Hongyan, Deng Xiangbin, Yang Weizhi, Li Duoyun, Liu Xiaojun, Deng Qiwen. Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/906026
|
| 10 |
Ke-Qin Hu, Wei Cui, Susan D Rouster, Kenneth E Sherman. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals. World Journal of Hepatology 2019; 11(5): 442-449 doi: 10.4254/wjh.v11.i5.442
|
| 11 |
Jian Tao, Weimin Zhang, Huakui Yue, Guohun Zhu, Wenyuan Wu, Wenbo Gong, Honghui Fang, Guirong He, Xiaoyun Hu, Hongyue Zhao, Aiqin Liu. Prevalence of Hepatitis B Virus Infection in Shenzhen, China, 2015–2018. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50173-5
|
| 12 |
Tingting Li, Shu Su, Yong Zhao, Runze Deng, Mingyue Fan, Ruoxi Wang, Manoj Sharma, Huan Zeng. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. International Journal of Environmental Research and Public Health 2019; 16(2): 231 doi: 10.3390/ijerph16020231
|
| 13 |
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?. Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509
|
| 14 |
Jinyuan Wei, Yongyu Mei, Jianping Li, Jing Yuan, Xiaohua Yang, Zhen Xu, Guoli Lin, Juan Zhang, Zhixin Zhao, Xiaohong Zhang. Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection. Liver Research 2020; 4(2): 101 doi: 10.1016/j.livres.2020.05.002
|
| 15 |
Qin Ning, Ting Wu, Hai-Bin Su, Ke Ma, Jun-Ying Qi, Ming Ni, Di Wu. Acute Exacerbation of Chronic Hepatitis B. 2019; : 371 doi: 10.1007/978-94-024-1603-9_5
|
| 16 |
Qing Xie, Jian-Wei Xuan, Hong Tang, Xiao-Guang Ye, Peng Xu, I-Heng Lee, Shan-Lian Hu. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China. World Journal of Hepatology 2019; 11(5): 421-441 doi: 10.4254/wjh.v11.i5.421
|